Shopping Cart
Remove All
Your shopping cart is currently empty
Anti-B7-1 Antibody (2Z423) (Synonyms: CD80 molecule)
Catalog No. TMAY-01081 Copy Product Info
🥰Excellent
Anti-B7-1 Antibody (2Z423) is a Rabbit antibody targeting B7-1. Anti-B7-1 Antibody (2Z423) can be used in ELISA.
Anti-B7-1 Antibody (2Z423)
Copy Product Info🥰Excellent
Catalog No. TMAY-01081
Synonyms CD80 molecule
Anti-B7-1 Antibody (2Z423) is a Rabbit antibody targeting B7-1. Anti-B7-1 Antibody (2Z423) can be used in ELISA.
Anti-B7-1 Antibody
(2Z423)
(2Z423)
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 20 μL | $93 | 7-10 days | 7-10 days | |
| 100 μL | $269 | 7-10 days | 7-10 days |
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Stability & Storage
| Description | Anti-B7-1 Antibody (2Z423) is a Rabbit antibody targeting B7-1. Anti-B7-1 Antibody (2Z423) can be used in ELISA. |
| Synonyms | CD80 molecule |
| Ig Type | Rabbit IgG |
| Clone | 2Z423 |
| Reactivity | Human |
| Specificity | Human B7-1/CD80 |
| Application | |
| Recommended Dose | ELISA: 1:5000-1:10000 |
| Antibody Type | Monoclonal |
| Host Species | Rabbit |
| Construction | This antibody was obtained from a rabbit immunized with purified, recombinant Human CD80 / B7-1 (rh CD80 / B7-1; TMPY-01063; NP_005182.1; Met1-Asn242). |
| Purification | Protein A |
| Appearance | Liquid |
| Formulation | 0.2 μm filtered solution in PBS |
| Research Background | The B-lymphocyte activation antigen B7-1 (referred to as B7), also known as CD80, is a member of cell surface immunoglobulin superfamily and is expressed on the surface of antigen-presenting cells including activated B cells, macrophages and dendritic cells. As costimulatory ligands, B7-1 which exists predominantly as dimer and the related protein B7-2, interact with the costimulatory receptors CD28 and cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) expressed on T cells, and thus constitute one of the dominant pathways that regulate T cell activation and tolerance, cytokine production, and the generation of CTL. The B7/CD28/CTLA4 pathway has the ability to both positively and negatively regulate immune responses. CD80 is thus regarded as promising therapeutic targets for autoimmune diseases and various carcinomas.Cancer ImmunotherapyCo-inhibitory Immune Checkpoint TargetsImmune CheckpointImmune Checkpoint Detection: AntibodiesImmune Checkpoint Detection: ELISA AntibodiesImmune Checkpoint Detection: FCM AntibodiesImmune Checkpoint Detection: IHC AntibodiesImmune Checkpoint Detection: WB AntibodiesImmune Checkpoint ProteinsImmune Checkpoint TargetsImmunotherapyTargeted Therapy |
| Conjucates | Unconjugated |
| Immunogen | Recombinant Protein: Human CD80 / B7-1 Protein (TMPY-01063) |
| Antigen Species | Human |
| Biology Area | Cancer Drug Targets |
| Stability & Storage | Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free. |
| Transport | Shipping with blue ice. |
Calculator
Preview
Related Tags: buy Anti-B7-1 Antibody (2Z423) | purchase Anti-B7-1 Antibody (2Z423) | Anti-B7-1 Antibody (2Z423) cost | order Anti-B7-1 Antibody (2Z423)
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.